Pharmaceutical Contract Manufacturing Market 2024, By Services Type (Pharmaceutical Manufacturing Services, Pharmaceutical API Manufacturing Services, Drug Development Services, Biologic Manufacturing Services, Biologic API Manufacturing Services, Others), By End User (Large Pharmaceutical Companies, Small & Mid Sized Pharmaceutical Companies, Generic Pharmaceutical Companies, Others) and Region – Global Dynamics, Trends & Forecast

Number of pages: 200+  |  Report Format: PDF  |  Published date: July, 2024
Historical Years – 2018-2022  |  Base Year – 2023  |  Forecasted Years – 2024 to 2033

A new report titled “Pharmaceutical Contract Manufacturing Market – Forecast to 2033” by Eternal Markets, the global Pharmaceutical Contract Manufacturing industry is projected to grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2033, reaching a value of USD 342.7 billion by the end of the forecast period.

Overview

The global pharmaceutical contract manufacturing market is witnessing significant growth driven by the increasing outsourcing of manufacturing processes by pharmaceutical companies to focus on core competencies, reduce costs, and expedite time-to-market. Pharmaceutical contract manufacturing organizations (CMOs) provide a range of services, including pharmaceutical manufacturing, API manufacturing, drug development, and biologic manufacturing. This growth is propelled by the rising demand for pharmaceutical products, advancements in manufacturing technologies, and stringent regulatory requirements ensuring high-quality production standards.

Key Visions

  • Estimated CAGR: Around 8.2% over the forecast period (2024-2033).
  • Market Size Projection: The global pharmaceutical contract manufacturing industry size is projected to reach USD 342.7 billion by 2033 from USD 168.4 billion in 2023.
  • Key Driver: Increasing outsourcing of manufacturing processes by pharmaceutical companies.
  • By Services Type: In 2023, the pharmaceutical manufacturing services segment held the largest market share due to the high demand for outsourced manufacturing services.
  • By End User: The large pharmaceutical companies segment is likely to be the largest revenue contributor in 2033, driven by the need to reduce operational costs and focus on R&D.
  • By Region: North America held the largest market share in 2023, due to its well-established pharmaceutical industry and presence of major CMOs.

Key Market Drivers

Cost Reduction: Outsourcing manufacturing processes helps pharmaceutical companies reduce operational and production costs.

Focus on Core Competencies: Enables pharmaceutical companies to focus on core activities such as R&D, marketing, and sales.

Regulatory Compliance: CMOs offer expertise in regulatory compliance, ensuring high-quality and standardized production processes.

Technological Advancements: Adoption of advanced manufacturing technologies and processes by CMOs enhances production efficiency and quality.

Capacity Flexibility: CMOs provide scalable manufacturing solutions, allowing pharmaceutical companies to manage production volumes based on demand.

Time-to-Market: Outsourcing to CMOs can accelerate the time-to-market for new drugs, providing a competitive edge to pharmaceutical companies.

Restraining Factors

Quality Concerns: Potential risks associated with the quality and reliability of outsourced manufacturing processes may hinder market growth.

Intellectual Property Risks: Concerns related to intellectual property rights and data security can limit the adoption of outsourcing.

Dependency on CMOs: Over-reliance on CMOs for manufacturing processes can lead to supply chain disruptions and operational challenges.

Future Scope

Expansion in Emerging Markets: Significant growth opportunities exist in emerging markets due to increasing pharmaceutical production and outsourcing activities.

Technological Innovations: Continued advancements in manufacturing technologies will improve production efficiency and product quality.

Strategic Collaborations: Partnerships between pharmaceutical companies and CMOs will drive market expansion and innovation.

Regulatory Evolution: Evolving regulatory frameworks will ensure higher standards of quality and safety in outsourced manufacturing processes.

Sustainable Practices: Growing emphasis on sustainable and eco-friendly manufacturing practices will shape the future of pharmaceutical contract manufacturing.

Major Strategies adopted by key market players.

  • Agreements, Collaborations, and Partnerships: 21%
  • Acquisitions: 15%
  • New Product Launch: _%
  • Other Developments: _%

Geographical Analysis

North America held the largest market share in 2023, driven by the region’s well-established pharmaceutical industry, advanced manufacturing infrastructure, and the presence of major CMOs. The U.S. and Canada are key contributors to the market in this region, benefiting from significant investments in pharmaceutical R&D and manufacturing capabilities.

The Asia-Pacific region is expected to witness substantial growth during the forecast period, driven by increasing pharmaceutical production, growing outsourcing activities, and expanding healthcare infrastructure. Countries such as China, Japan, and India are key contributors to market expansion in this region, supported by rapid economic development and favorable government initiatives.

Recent Developments

  • 2023: Sai Life Sciences Limited announced the expansion of its manufacturing capabilities with the opening of a new state-of-the-art facility.
  • 2022: PCI Pharma Services acquired a major pharmaceutical manufacturing company to strengthen its global presence and service offerings.
  • 2022: Charles River Laboratories launched a new suite of drug development services to support the growing demand for pharmaceutical outsourcing.
  • 2021: Cambrex Corporation entered into a strategic partnership with a leading pharmaceutical company to provide end-to-end manufacturing solutions.

Scope of the Report:

Global Pharmaceutical Contract Manufacturing Market, By Services Type

  • Pharmaceutical Manufacturing Services
  • Pharmaceutical API Manufacturing Services
  • Drug Development Services
  • Biologic Manufacturing Services
  • Biologic API Manufacturing Services
  • Others

Global Pharmaceutical Contract Manufacturing Market, By End User

  • Large Pharmaceutical Companies
  • Small & Mid Sized Pharmaceutical Companies
  • Generic Pharmaceutical Companies
  • Others

Global Pharmaceutical Contract Manufacturing Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of APAC (RoAPAC)
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • GCC
    • Israel
    • South Africa
    • Rest of MEA

Companies Profiled

● Sai Life Sciences Limited
● PCI Pharma Services
● Lannett Company, Inc.
● Cambrex Corporation
● Charles River Laboratories
● Curia Global, Inc.
● Famar Healthcare Services
● Delpharm Holdings
● Yuhan Corporation
● Syngene International Limited (Biocon Limited)
● Other key players

*The report scope shall be customized as per the requirements

Chapter 1 Global Pharmaceutical Contract Manufacturing Market Overview
1.1 Introduction
1.2 Drivers for Pharmaceutical Contract Manufacturing Market
1.3 Restraints for Pharmaceutical Contract Manufacturing Market
1.4 Opportunities for Pharmaceutical Contract Manufacturing Market
1.5 Trends for Pharmaceutical Contract Manufacturing Market
1.6 Macro-economic Factors
1.7 Regulatory Framework
1.8 Opportunity Map Analysis
1.9 Opportunity Orbits
1.10 Market Investment Feasibility Index
1.11 PEST Analysis
1.12 PORTER’S Five Force Analysis
1.13 Go to Market Strategy
1.14 Marketing Strategy
1.15 Technology Roadmap
1.16 Advances in product/services adoption worldwide
1.17 Regional Market Share and BPS Analysis
Chapter 2 Global Pharmaceutical Contract Manufacturing Market Competitive Analysis
2.1 Market Competition Scenario Analysis, By Company
2.2 Competitor Landscape
2.3 Major Strategies adopted by key market players (2020-2022)
2.4 Recent Developments/Investments/Announcements
2.5 Company Profiles
2.5.1 Sai Life Sciences Limited
2.5.1.1 Company Overview
2.5.1.2 Business Description
2.5.1.3 Product Portfolio
2.5.1.4 Key Financials
2.5.1.5 Company Presence & Business Segment Analysis – 2022
2.5.1.6 Key Developments
2.5.1.7 SWOT Analysis
2.5.2 PCI Pharma Services
2.5.2.1 Company Overview
2.5.2.2 Business Description
2.5.2.3 Product Portfolio
2.5.2.4 Key Financials
2.5.2.5 Company Presence & Business Segment Analysis – 2022
2.5.2.6 Key Developments
2.5.2.7 SWOT Analysis
2.5.3 Lannett Company, Inc.
2.5.3.1 Company Overview
2.5.3.2 Business Description
2.5.3.3 Product Portfolio
2.5.3.4 Key Financials
2.5.3.5 Company Presence & Business Segment Analysis – 2022
2.5.3.6 Key Developments
2.5.3.7 SWOT Analysis
2.5.4 Cambrex Corporation
2.5.4.1 Company Overview
2.5.4.2 Business Description
2.5.4.3 Product Portfolio
2.5.4.4 Key Financials
2.5.4.5 Company Presence & Business Segment Analysis – 2022
2.5.4.6 Key Developments
2.5.4.7 SWOT Analysis
2.5.5 Charles River Laboratories
2.5.5.1 Company Overview
2.5.5.2 Business Description
2.5.5.3 Product Portfolio
2.5.5.4 Key Financials
2.5.5.5 Company Presence & Business Segment Analysis – 2022
2.5.5.6 Key Developments
2.5.5.7 SWOT Analysis
2.5.6 Curia Global, Inc.
2.5.6.1 Company Overview
2.5.6.2 Business Description
2.5.6.3 Product Portfolio
2.5.6.4 Key Financials
2.5.6.5 Company Presence & Business Segment Analysis – 2022
2.5.6.6 Key Developments
2.5.6.7 SWOT Analysis
2.5.7 Famar Healthcare Services
2.5.7.1 Company Overview
2.5.7.2 Business Description
2.5.7.3 Product Portfolio
2.5.7.4 Key Financials
2.5.7.5 Company Presence & Business Segment Analysis – 2022
2.5.7.6 Key Developments
2.5.7.7 SWOT Analysis
2.5.8 Delpharm Holdings
2.5.8.1 Company Overview
2.5.8.2 Business Description
2.5.8.3 Product Portfolio
2.5.8.4 Key Financials
2.5.8.5 Company Presence & Business Segment Analysis – 2022
2.5.8.6 Key Developments
2.5.8.7 SWOT Analysis
2.5.9 Yuhan Corporation
2.5.9.1 Company Overview
2.5.9.2 Business Description
2.5.9.3 Product Portfolio
2.5.9.4 Key Financials
2.5.9.5 Company Presence & Business Segment Analysis – 2022
2.5.9.6 Key Developments
2.5.9.7 SWOT Analysis
2.5.10 Syngene International Limited (Biocon Limited)
2.5.10.1 Company Overview
2.5.10.2 Business Description
2.5.10.3 Product Portfolio
2.5.10.4 Key Financials
2.5.10.5 Company Presence & Business Segment Analysis – 2022
2.5.10.6 Key Developments
2.5.10.7 SWOT Analysis
Chapter 3 Global Pharmaceutical Contract Manufacturing Market Overview
3.1 Global Pharmaceutical Contract Manufacturing Market Outlook (2017-2032)
3.1.1 Global Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) (2017-2023)
3.1.2 Global Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) (2024-2032)
3.2 Global Pharmaceutical Contract Manufacturing Market by Region
3.2.1 Global Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
3.2.2 Global Pharmaceutical Contract Manufacturing Market Attractiveness Analysis by Region, 2023–2032
3.3 Global Pharmaceutical Contract Manufacturing Market by Services Type
3.3.1 Global Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Services Type (2017-2032)
3.3.2 Global Pharmaceutical Contract Manufacturing Market Attractiveness Analysis by Services Type, 2023–2032
3.3.3 Global Pharmaceutical Contract Manufacturing Market Attractiveness Analysis by Region, 2023–2032
3.4 Global Pharmaceutical Contract Manufacturing Market by End User
3.4.1 Global Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by End User (2017-2032)
3.4.2 Global Pharmaceutical Contract Manufacturing Market Attractiveness Analysis by End User, 2023–2032
3.5 Global Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) by Region
3.5.1 Global Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
3.5.2 Global Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
3.6 Global Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) by Services Type
3.6.1 Global Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Services Type (2017-2023)
3.6.2 Global Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Services Type (2024-2032)
3.7 Global Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) by End User
3.7.1 Global Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by End User (2017-2023)
3.7.2 Global Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by End User (2024-2032)
3.8 Global Pharmaceutical Contract Manufacturing Market Y-o-Y Growth Rate Comparison 2018–2032
3.8.1 Global Pharmaceutical Contract Manufacturing Market Y-o-Y Growth Rate by Region
3.8.2 Global Pharmaceutical Contract Manufacturing Market Y-o-Y Growth Rate by Services Type
3.8.3 Global Pharmaceutical Contract Manufacturing Market Y-o-Y Growth Rate by End User
3.9 Global Pharmaceutical Contract Manufacturing Market Share Comparison 2017–2032
3.9.1 Global Pharmaceutical Contract Manufacturing Market Share by Region
3.9.2 Global Pharmaceutical Contract Manufacturing Market Share by Services Type
3.9.3 Global Pharmaceutical Contract Manufacturing Market Share by End User
Chapter 4 North America Pharmaceutical Contract Manufacturing Market Overview
4.1 North America Market Snapshot
4.1.1 Regional Overview
4.1.1.1 US
4.1.1.2 Canada
4.1.1.3 Mexico
4.2 North America Pharmaceutical Contract Manufacturing Market Outlook (2017-2032)
4.2.1 North America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) (2017-2023)
4.2.2 North America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) (2024-2032)
4.3 North America Pharmaceutical Contract Manufacturing Market by Region
4.3.1 North America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
4.3.2 North America Pharmaceutical Contract Manufacturing Market Attractiveness Analysis by Region, 2023–2032
4.4 North America Pharmaceutical Contract Manufacturing Market by Services Type
4.4.1 North America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Services Type (2017-2032)
4.4.2 North America Pharmaceutical Contract Manufacturing Market Attractiveness Analysis by Services Type, 2023–2032
4.4.3 North America Pharmaceutical Contract Manufacturing Market Attractiveness Analysis by Region, 2023–2032
4.5 North America Pharmaceutical Contract Manufacturing Market by End User
4.5.1 North America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by End User (2017-2032)
4.5.2 North America Pharmaceutical Contract Manufacturing Market Attractiveness Analysis by End User, 2023–2032
4.6 North America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) by Region
4.6.1 North America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
4.6.2 North America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
4.7 North America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) by Services Type
4.7.1 North America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Services Type (2017-2023)
4.7.2 North America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Services Type (2024-2032)
4.8 North America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) by End User
4.8.1 North America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by End User (2017-2023)
4.8.2 North America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by End User (2024-2032)
4.9 North America Pharmaceutical Contract Manufacturing Market Y-o-Y Growth Rate Comparison 2018–2032
4.9.1 North America Pharmaceutical Contract Manufacturing Market Y-o-Y Growth Rate by Region
4.9.2 North America Pharmaceutical Contract Manufacturing Market Y-o-Y Growth Rate by Services Type
4.9.3 North America Pharmaceutical Contract Manufacturing Market Y-o-Y Growth Rate by End User
4.1 North America Pharmaceutical Contract Manufacturing Market Share Comparison 2017–2032
4.10.1 North America Pharmaceutical Contract Manufacturing Market Share by Region
4.10.2 North America Pharmaceutical Contract Manufacturing Market Share by Services Type
4.10.3 North America Pharmaceutical Contract Manufacturing Market Share by End User
Chapter 5 Europe Pharmaceutical Contract Manufacturing Market Overview
5.1 Europe Market Snapshot
5.1.1 Regional Overview
5.1.1.1 Germany
5.1.1.2 United Kingdom
5.1.1.3 France
5.1.1.4 Italy
5.1.1.5 Spain
5.1.1.6 Russia
5.1.1.7 Rest of Europe
5.2 Europe Pharmaceutical Contract Manufacturing Market Outlook (2017-2032)
5.2.1 Europe Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) (2017-2023)
5.2.2 Europe Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) (2024-2032)
5.3 Europe Pharmaceutical Contract Manufacturing Market by Region
5.3.1 Europe Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
5.3.2 Europe Pharmaceutical Contract Manufacturing Market Attractiveness Analysis by Region, 2023–2032
5.4 Europe Pharmaceutical Contract Manufacturing Market by Services Type
5.4.1 Europe Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Services Type (2017-2032)
5.4.2 Europe Pharmaceutical Contract Manufacturing Market Attractiveness Analysis by Services Type, 2023–2032
5.4.3 Europe Pharmaceutical Contract Manufacturing Market Attractiveness Analysis by Region, 2023–2032
5.5 Europe Pharmaceutical Contract Manufacturing Market by End User
5.5.1 Europe Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by End User (2017-2032)
5.5.2 Europe Pharmaceutical Contract Manufacturing Market Attractiveness Analysis by End User, 2023–2032
5.6 Europe Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) by Region
5.6.1 Europe Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
5.6.2 Europe Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
5.7 Europe Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) by Services Type
5.7.1 Europe Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Services Type (2017-2023)
5.7.2 Europe Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Services Type (2024-2032)
5.8 Europe Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) by End User
5.8.1 Europe Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by End User (2017-2023)
5.8.2 Europe Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by End User (2024-2032)
5.9 Europe Pharmaceutical Contract Manufacturing Market Y-o-Y Growth Rate Comparison 2018–2032
5.9.1 Europe Pharmaceutical Contract Manufacturing Market Y-o-Y Growth Rate by Region
5.9.2 Europe Pharmaceutical Contract Manufacturing Market Y-o-Y Growth Rate by Services Type
5.9.3 Europe Pharmaceutical Contract Manufacturing Market Y-o-Y Growth Rate by End User
5.1 Europe Pharmaceutical Contract Manufacturing Market Share Comparison 2017–2032
5.10.1 Europe Pharmaceutical Contract Manufacturing Market Share by Region
5.10.2 Europe Pharmaceutical Contract Manufacturing Market Share by Services Type
5.10.3 Europe Pharmaceutical Contract Manufacturing Market Share by End User
Chapter 6 Asia Pacific Pharmaceutical Contract Manufacturing Market Overview
6.1 Asia Pacific Market Snapshot
6.1.1 Regional Overview
6.1.1.1 China
6.1.1.2 India
6.1.1.3 Japan
6.1.1.4 Australia
6.1.1.5 Rest of Asia Pacific
6.2 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook (2017-2032)
6.2.1 Asia Pacific Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) (2017-2023)
6.2.2 Asia Pacific Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) (2024-2032)
6.3 Asia Pacific Pharmaceutical Contract Manufacturing Market by Region
6.3.1 Asia Pacific Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
6.3.2 Asia Pacific Pharmaceutical Contract Manufacturing Market Attractiveness Analysis by Region, 2023–2032
6.4 Asia Pacific Pharmaceutical Contract Manufacturing Market by Services Type
6.4.1 Asia Pacific Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Services Type (2017-2032)
6.4.2 Asia Pacific Pharmaceutical Contract Manufacturing Market Attractiveness Analysis by Services Type, 2023–2032
6.4.3 Asia Pacific Pharmaceutical Contract Manufacturing Market Attractiveness Analysis by Region, 2023–2032
6.5 Asia Pacific Pharmaceutical Contract Manufacturing Market by End User
6.5.1 Asia Pacific Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by End User (2017-2032)
6.5.2 Asia Pacific Pharmaceutical Contract Manufacturing Market Attractiveness Analysis by End User, 2023–2032
6.6 Asia Pacific Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) by Region
6.6.1 Asia Pacific Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
6.6.2 Asia Pacific Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
6.7 Asia Pacific Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) by Services Type
6.7.1 Asia Pacific Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Services Type (2017-2023)
6.7.2 Asia Pacific Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Services Type (2024-2032)
6.8 Asia Pacific Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) by End User
6.8.1 Asia Pacific Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by End User (2017-2023)
6.8.2 Asia Pacific Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by End User (2024-2032)
6.9 Asia Pacific Pharmaceutical Contract Manufacturing Market Y-o-Y Growth Rate Comparison 2018–2032
6.9.1 Asia Pacific Pharmaceutical Contract Manufacturing Market Y-o-Y Growth Rate by Region
6.9.2 Asia Pacific Pharmaceutical Contract Manufacturing Market Y-o-Y Growth Rate by Services Type
6.9.3 Asia Pacific Pharmaceutical Contract Manufacturing Market Y-o-Y Growth Rate by End User
6.1 Asia Pacific Pharmaceutical Contract Manufacturing Market Share Comparison 2017–2032
6.10.1 Asia Pacific Pharmaceutical Contract Manufacturing Market Share by Region
6.10.2 Asia Pacific Pharmaceutical Contract Manufacturing Market Share by Services Type
6.10.3 Asia Pacific Pharmaceutical Contract Manufacturing Market Share by End User
Chapter 7 South America Pharmaceutical Contract Manufacturing Market Overview
7.1 South America Market Snapshot
7.1.1 Regional Overview
7.1.1.1 Brazil
7.1.1.2 Argentina
7.1.1.3 Rest of South America
7.2 South America Pharmaceutical Contract Manufacturing Market Outlook (2017-2032)
7.2.1 South America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) (2017-2023)
7.2.2 South America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) (2024-2032)
7.3 South America Pharmaceutical Contract Manufacturing Market by Region
7.3.1 South America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
7.3.2 South America Pharmaceutical Contract Manufacturing Market Attractiveness Analysis by Region, 2023–2032
7.4 South America Pharmaceutical Contract Manufacturing Market by Services Type
7.4.1 South America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Services Type (2017-2032)
7.4.2 South America Pharmaceutical Contract Manufacturing Market Attractiveness Analysis by Services Type, 2023–2032
7.4.3 South America Pharmaceutical Contract Manufacturing Market Attractiveness Analysis by Region, 2023–2032
7.5 South America Pharmaceutical Contract Manufacturing Market by End User
7.5.1 South America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by End User (2017-2032)
7.5.2 South America Pharmaceutical Contract Manufacturing Market Attractiveness Analysis by End User, 2023–2032
7.6 South America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) by Region
7.6.1 South America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
7.6.2 South America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
7.7 South America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) by Services Type
7.7.1 South America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Services Type (2017-2023)
7.7.2 South America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Services Type (2024-2032)
7.8 South America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) by End User
7.8.1 South America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by End User (2017-2023)
7.8.2 South America Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by End User (2024-2032)
7.9 South America Pharmaceutical Contract Manufacturing Market Y-o-Y Growth Rate Comparison 2018–2032
7.9.1 South America Pharmaceutical Contract Manufacturing Market Y-o-Y Growth Rate by Region
7.9.2 South America Pharmaceutical Contract Manufacturing Market Y-o-Y Growth Rate by Services Type
7.9.3 South America Pharmaceutical Contract Manufacturing Market Y-o-Y Growth Rate by End User
7.1 South America Pharmaceutical Contract Manufacturing Market Share Comparison 2017–2032
7.10.1 South America Pharmaceutical Contract Manufacturing Market Share by Region
7.10.2 South America Pharmaceutical Contract Manufacturing Market Share by Services Type
7.10.3 South America Pharmaceutical Contract Manufacturing Market Share by End User
Chapter 8 Middle East and Africa Pharmaceutical Contract Manufacturing Market Overview
8.1 Middle East and Africa Market Snapshot
8.1.1 Regional Overview
8.1.1.1 GCC
8.1.1.2 South Africa
8.1.1.3 Israel
8.1.1.4 Rest of Middle East and Africa
8.2 Middle East and Africa Pharmaceutical Contract Manufacturing Market Outlook (2017-2032)
8.2.1 Middle East and Africa Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) (2017-2023)
8.2.2 Middle East and Africa Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) (2024-2032)
8.3 Middle East and Africa Pharmaceutical Contract Manufacturing Market by Region
8.3.1 Middle East and Africa Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
8.3.2 Middle East and Africa Pharmaceutical Contract Manufacturing Market Attractiveness Analysis by Region, 2023–2032
8.4 Middle East and Africa Pharmaceutical Contract Manufacturing Market by Services Type
8.4.1 Middle East and Africa Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Services Type (2017-2032)
8.4.2 Middle East and Africa Pharmaceutical Contract Manufacturing Market Attractiveness Analysis by Services Type, 2023–2032
8.4.3 Middle East and Africa Pharmaceutical Contract Manufacturing Market Attractiveness Analysis by Region, 2023–2032
8.5 Middle East and Africa Pharmaceutical Contract Manufacturing Market by End User
8.5.1 Middle East and Africa Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by End User (2017-2032)
8.5.2 Middle East and Africa Pharmaceutical Contract Manufacturing Market Attractiveness Analysis by End User, 2023–2032
8.6 Middle East and Africa Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) by Region
8.6.1 Middle East and Africa Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
8.6.2 Middle East and Africa Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
8.7 Middle East and Africa Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) by Services Type
8.7.1 Middle East and Africa Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Services Type (2017-2023)
8.7.2 Middle East and Africa Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by Services Type (2024-2032)
8.8 Middle East and Africa Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) by End User
8.8.1 Middle East and Africa Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by End User (2017-2023)
8.8.2 Middle East and Africa Pharmaceutical Contract Manufacturing Market Value (US$ Mn) and Volume (Units) Comparison by End User (2024-2032)
8.9 Middle East and Africa Pharmaceutical Contract Manufacturing Market Y-o-Y Growth Rate Comparison 2018–2032
8.9.1 Middle East and Africa Pharmaceutical Contract Manufacturing Market Y-o-Y Growth Rate by Region
8.9.2 Middle East and Africa Pharmaceutical Contract Manufacturing Market Y-o-Y Growth Rate by Services Type
8.9.3 Middle East and Africa Pharmaceutical Contract Manufacturing Market Y-o-Y Growth Rate by End User
8.1 Middle East and Africa Pharmaceutical Contract Manufacturing Market Share Comparison 2017–2032
8.10.1 Middle East and Africa Pharmaceutical Contract Manufacturing Market Share by Region
8.10.2 Middle East and Africa Pharmaceutical Contract Manufacturing Market Share by Services Type
8.10.3 Middle East and Africa Pharmaceutical Contract Manufacturing Market Share by End User
Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources

License

Single User, Corporate User, Data Pack / Excel
Single User
$3,499
Corporate User
$6,999
Data Pack / Excel
$999
Compare Added ♡ Add to Wishlist♥ Browse Wishlist

Related products

Compare Products
No products were added to compare list
Return to Shop
Electrolyte Drinks Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Food Colors Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Used Cooking Oil Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Nutritional Food and Drink Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Dietary Fibers Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Luxury Wines and Spirits Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Cooking Oils and Fats Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Commercial Seaweeds Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Food Intolerance Products Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Processed Poultry Meat Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Processed Poultry Meat Market 2024, Global Dynamics, Trends & Forecast
VIEW DETAILS